Back to 
RHUMBLINE ADVISERS
RHUMBLINE ADVISERS
KNTEShowing 0 of 14 quarters
Position history for RHUMBLINE ADVISERS's holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, RhumbLine Advisers held 2,933 shares of KNTE (Kinnate Biopharma), worth $7,801. RhumbLine Advisers' 13F filings listed KNTE from Q1 2021 to Q1 2024, 13 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., FMR LLC